|
The
company, which got almost half of its revenue from outside the
United States in 2015, said it expects 2016 full-year sales of
$70.8 billion-$71.5 billion.
Analysts on average were expecting sales of $71.88 billion,
according to Thomson Reuters I/B/E/S.
The dollar index, which measures the currency against a basket
of six other major currencies, rose 9 percent in 2015, after
rising 13 percent in 2014.
The company's net earnings rose about 28 percent to $3.22
billion, or $1.15 per share, in the fourth quarter.
On an adjusted basis, the company earned $1.44 per share, above
analysts' average estimate of $1.42.
Sales fell to $17.81 billion, but was largely in-line with the
average analyst estimate of $17.88 billion.
The band-aid maker, which said last week it would cut about
3,000 jobs within its struggling medical devices unit over the
next two years, said it expects adjusted earnings of $6.43-$6.58
per share for 2016.
Analysts on average were expecting earnings of $6.38 per share.
(Reporting by Ankur Banerjee in Bengaluru; Editing by Sriraj
Kalluvila)
[© 2016 Thomson Reuters. All rights
reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |
|
